Public health & consumer activist
Skip to content
  • Home
  • Contact
  • About
  • Involvement
  • Publications / Talks
  • Teaching & supervision
  • Photos
  • News blog

Tag Archives: delisting

TGA (and Pharmacy Board) fails to reign in shonky weight-loss product

Posted on October 22, 2012 by Dr Ken Harvey

Published in “The Conversation” today http://theconversation.edu.au/tga-once-again-fails-to-reign-in-shonky-weight-loss-product-10227 by

Posted in Pharmaceutical Promotion | Tagged AHPRA, Australian National Audit Office Report Complementary Medicine Regulation, Complaint Resolution Panel, delisting, FatBlaster Reducta, Pharmacare Laboratories, SensaSlim, TGA, Therapeutic Goods Advertising Code | Leave a comment
  • Pages

    • About
    • Contact
    • Home
    • Involvement
    • News blog
    • Photos
    • Publications / Talks
    • Teaching & supervision
  • Subscribe to my blog


     

  • Recent Blog Posts

    • Federal Election 2022 #4
    • Federal Election 2022 #3
    • Federal Election 2022 #2
    • Federal Election 2022 #1
    • Avemar, a Food for Special Medical Purposes for Cancer Patients?
    • TGA allows alcohol as a reward for COVID-19 vaccination
  • Themes

    • ABC
    • ACCC
    • advertisments
    • AHPRA
    • AMHC
    • AMI
    • Blackmores
    • Chiropractic Board
    • Complaint Resolution Panel
    • Complementary Medicines
    • consumers
    • COVID-19
    • CRP
    • Dr Jacqui Forrester
    • Dr Tom Goyer
    • food-medicine interface
    • Friends of Science in Medicine
    • FSANZ
    • FSM
    • Geoff Jowett
    • Greens
    • health professionals
    • homeopathic medicines
    • Medical Weightloss Institute
    • Medicines Australia
    • MMD Review
    • Monash University
    • MWI
    • Pharmacare Laboratories
    • promotion
    • Regulatory Reform
    • self-regulation
    • Senate Community Affairs Legislation Committee
    • Souvenaid
    • Swisse
    • Swisse Vitamins
    • TGA
    • TGACC
    • TGA Complaint system
    • TGACRP
    • Therapeutic Goods Act
    • Therapeutic Goods Advertising Code
    • Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017
    • Transparency
    • U3A
  • Archives

    • May 2022
    • April 2022
    • August 2021
    • July 2021
    • June 2021
    • April 2021
    • March 2021
    • February 2021
    • November 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017
    • August 2017
    • July 2017
    • June 2017
    • May 2017
    • March 2017
    • February 2017
    • January 2017
    • December 2016
    • November 2016
    • October 2016
    • September 2016
    • August 2016
    • July 2016
    • June 2016
    • April 2016
    • March 2016
    • February 2016
    • January 2016
    • December 2015
    • October 2015
    • September 2015
    • August 2015
    • July 2015
    • June 2015
    • May 2015
    • April 2015
    • March 2015
    • January 2015
    • December 2014
    • November 2014
    • October 2014
    • July 2014
    • March 2014
    • February 2014
    • January 2014
    • November 2013
    • October 2013
    • September 2013
    • August 2013
    • July 2013
    • June 2013
    • May 2013
    • April 2013
    • March 2013
    • February 2013
    • January 2013
    • December 2012
    • November 2012
    • October 2012
    • August 2012
    • July 2012
    • May 2012
    • April 2012
    • March 2012
    • June 2011
  • Subscribe2


     

Proudly powered by WordPress.